Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)
Clinical trial NCT06902857 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06902857
- Sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-18
- Primary completion
- 2028-12-31
- Enrollment
- 964
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.